OxTalks is Changing
Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Stem cell therapy for perinatal brain injuries
Despite the significant reduction in global neonatal mortality over the last 30 years, there are still numerous intractable perinatal diseases requiring novel therapies, including perinatal hypoxic-ischemic encephalopathy (HIE). Stem cell therapy is expected to be a promising treatment option for such diseases, as it has several advantages, such as the ability to replace injured cells, regenerate on their own, and produce growth factors that induce therapeutic effects. Moreover, stem cells can migrate to where they are needed, even when administered intravenously, and respond to the situation and location.
We are developing novel stem cell-based therapies for various perinatal diseases, focusing on HIE and bronchopulmonary dysplasia. Regarding HIE, we have conducted basic research on various types of stem cells, such as neural stem/progenitor cells, umbilical cord blood cells, and mesenchymal stem cells derived from various tissues. Among these stem cells, we have proceeded to a clinical trial with multilineage-differentiating stress-enduring cells.
Additionally, we are focusing on the treatment of neurological symptoms in the chronic phase, such as cerebral palsy, and are planning a clinical trial with stem cells from human exfoliated deciduous teeth (SHED), which have demonstrated treatment effects in the chronic phase after HIE by animal studies.
In this presentation, I will talk about basic, translational, and clinical studies on HIE and the potential of stem cell therapy as a novel treatment for perinatal brain injuries.
Date:
13 November 2023, 15:00
Venue:
Sherrington Library, off Parks Road OX1 3PT
Speaker:
Dr Yoshiaki Sato (Nagoya University Hospital)
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Professor Zoltan Molnar (DPAG, University of Oxford)
Organiser contact email address:
communications@dpag.ox.ac.uk
Host:
Professor Masahiro Tsuji (University of Oxford)
Part of:
Neuroscience Theme Guest Speakers (DPAG)
Booking required?:
Not required
Audience:
Members of the University only
Editors:
Peter Belk,
Hannah Simm
